Dr. Ward has a long and distinguished career in insurance and the London Market, serving as CEO of Lloyd’s of London from 2006 until 2013, during which time he helped transform the organisation and introduce digitisation across many of its processes.
Following his time at Lloyd’s, Richard was Non-Executive Chairman at Brit Insurance, chairing the syndicate through its IPO and subsequent sale to Fairfax. He was also Executive Chairman at Cunningham Lindsey Group and Non-Executive Director at Partnership Assurance Group.
Richard is currently the Senior Independent Non-Executive Director at Direct Line Group and, until recently, was Executive Chairman of Ardonagh Specialty.
We are delighted to welcome Richard to CFC. The last twelve months have brought many milestones for our business – from the launch of our new syndicate to a record-breaking private equity deal – and Richard’s arrival is yet another such milestone. Richard brings a wealth of experience and leadership working with some of the most notable names in our market, including Lloyd’s itself, and will be a tremendous asset to us as we move ahead. David Walsh, Group CEO of CFC
‘CFC is an incredible business with a brilliant culture and an exciting, ambitious roadmap. The passion that Dave and the extended leadership team have for their business is palpable, and I’m looking forward to joining them in the next phase of their journey,’ commented Dr. Ward.
The company also recently announced a significant new investment from Vitruvian and EQT and the launch of CFC Syndicate 1988.
